Structures by: Ponnuswamy M. N.
Total: 168
4-(4-Chlorophenyl)-1,2,3-selenadiazole
C8H5ClN2Se
IUCrData (2018) 3, 3 x180462
a=10.3353(9)Å b=14.0058(12)Å c=5.9540(4)Å
α=90° β=97.320(3)° γ=90°
C19H21N3O2
C19H21N3O2
Chemistry Central Journal (2015) 9, 17
a=9.1789(6)Å b=12.7776(9)Å c=16.0615(10)Å
α=89.255(4)° β=86.758(4)° γ=70.507(4)°
C19H22N2O
C19H22N2O
Chemistry Central Journal (2015) 9, 17
a=11.1980(5)Å b=12.2910(8)Å c=13.3610(4)Å
α=93.151(5)° β=97.650(3)° γ=92.660(4)°
(<i>E</i>)-<i>N</i>-(1<i>H</i>-Pyrrol-2-ylmethylidene)-2-{[(<i>E</i>)-(1<i>H</i>-pyrrol-2-ylmethylidene)amino]methyl}aniline
C17H16N4
IUCrData (2017) 2, 4 x170540
a=9.968(4)Å b=15.529(6)Å c=10.119(4)Å
α=90° β=102.558(9)° γ=90°
Chlorotriphenylphosphine-bis(N- diphenyl(carbamothioyl)benzamide)copper(i)
C58H47ClCuN4O2PS2,H2O
Dalton transactions (Cambridge, England : 2003) (2011) 40, 46 12519-12526
a=21.1426(15)Å b=10.4879(8)Å c=25.0570(17)Å
α=90.00° β=108.708(3)° γ=90.00°
Chloro-bis(triphenylphosphine)-(N- diethyl(carbamothioyl)benzamide)copper(i)
C48H46ClCuN2OP2S
Dalton transactions (Cambridge, England : 2003) (2011) 40, 46 12519-12526
a=10.1804(6)Å b=19.6686(12)Å c=22.4500(14)Å
α=90.00° β=101.886(3)° γ=90.00°
N-Methyl-2,4-diphenyl-7-tertiary butyl 3-azabicyclo[3.3.1]nonane
C25H33N
Acta Crystallographica Section B (1999) 55, 5 793-798
a=13.6670(10)Å b=16.414(2)Å c=9.4090(10)Å
α=90.00° β=94.540(10)° γ=90.00°
N-Acetyl-2,4-diphenyl-3-azabicyclo[3.3.1]nonane
C22H25NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=14.6870(10)Å b=12.9310(10)Å c=18.5640(10)Å
α=90.00° β=90.00° γ=90.00°
N-Methyl-2,4-diorthomethyl phenyl-9-hydroxy 3-azabicyclo[3.3.1]nonane
C23H29NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=7.6380(10)Å b=13.1880(10)Å c=18.865(2)Å
α=90.00° β=97.940(10)° γ=90.00°
Piperazine-1,4-diium bis(4-aminobenzenesulfonate)
C4H12N22,2(C6H6NO3S)
Acta Crystallographica Section E (2015) 71, 12 o1084-o1085
a=10.1709(4)Å b=8.4461(3)Å c=21.5569(9)Å
α=90.00° β=90.00° γ=90.00°
5-Benzyl-8-(E)-benzylidene-6,7,7a,10a-tetrahydro-5H-cis- cyclopenta[5,6]pyrano[3,3-c]quinolin-6-one
C29H23NO2
Acta Crystallographica Section E (2004) 60, 10 o1699-o1701
a=8.422(2)Å b=10.585(3)Å c=12.866(3)Å
α=79.879(4)° β=76.281(4)° γ=79.042(4)°
2,4-Bis(pyridine-2-carbonyl)-1-(2-pyridyl)-3,5-bis(4-tolyl)cyclohex-1-ol
C37H33N3O3
Acta Crystallographica Section E (2004) 60, 12 o2353-o2355
a=8.534(7)Å b=34.067(10)Å c=10.458(5)Å
α=90.00° β=98.91(5)° γ=90.00°
C39H38N2O5
C39H38N2O5
Acta Crystallographica Section E (2002) 58, 6 o685-o686
a=11.22840(10)Å b=12.6346(4)Å c=12.9056(3)Å
α=102.453(2)° β=96.412(2)° γ=109.7750(10)°
2,2'-{(Z)-Ethane-1,2-diylbis[(Z)-o-phenylenenitrilomethylidyne]}diphenol
C28H24N2O2
Acta Crystallographica Section E (2004) 60, 6 o1078-o1080
a=11.817(3)Å b=13.762(6)Å c=6.873(2)Å
α=90.00° β=101.15(3)° γ=90.00°
Methyl 4-oxo-r-2,c-6-diphenylpiperidine-3-carboxylate
C19H19NO3
Acta Crystallographica Section E (2004) 60, 11 o2105-o2106
a=9.7563(13)Å b=7.7100(10)Å c=22.810(3)Å
α=90.00° β=102.348(4)° γ=90.00°
Diisopropyl 2-(2-benzoyl-1-phenylethyl)malonate
C24H28O5
Acta Crystallographica Section E (2002) 58, 3 o334-o335
a=6.0310(10)Å b=10.2147(10)Å c=19.0691(10)Å
α=74.759(10)° β=89.109(10)° γ=76.871(10)°
9,10-Bis(3-hydroxy-3,3-diphenylprop-1-ynyl)anthracene N,N'dimethylformamide solvate
C47H37NO3
Acta Crystallographica Section E (2002) 58, 2 o88-o89
a=16.290(3)Å b=11.837(2)Å c=19.426(4)Å
α=90.00° β=104.11(3)° γ=90.00°
Ethyl 3-methyl-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carboxylate
C13H12N4O6
Acta Crystallographica Section E (2003) 59, 11 o1835-o1837
a=7.7531(8)Å b=9.7146(10)Å c=11.4051(12)Å
α=113.649(2)° β=92.989(2)° γ=109.089(2)°
4'-(2-Chlorophenyl)-2,3-dihydro-1'-methyl-3'-nitrospiro[1H-indole-3,2'- pyrrolidin]-2-one
C18H16ClN3O3
Acta Crystallographica Section E (2004) 60, 10 o1862-o1864
a=13.1473(3)Å b=7.8193(12)Å c=17.4268(6)Å
α=90.00° β=102.086(2)° γ=90.00°
N-(2-Benzoyl-4-chlorophenyl)-2-chloroacetamide
C15H11Cl2NO2
Acta Crystallographica Section E (2005) 61, 3 o632-o634
a=5.9991(15)Å b=10.052(3)Å c=12.161(3)Å
α=81.391(4)° β=76.933(4)° γ=81.214(4)°
3-Benzyl-2-methyl-1-phenylsulfonyl-1H-indole
C22H19NO2S
Acta Crystallographica Section E (2005) 61, 3 o521-o523
a=17.160(9)Å b=11.680(6)Å c=18.274(10)Å
α=90.00° β=90.00° γ=90.00°
2,2'-Diaminodibenzyl
C14H16N2
Acta Crystallographica Section E (2005) 61, 4 o843-o845
a=5.4716(4)Å b=12.4800(10)Å c=16.6950(10)Å
α=90.00° β=90.00° γ=90.00°
4'-(4-Bromobenzoyl)-1'-methyl-dispiro[indole-3(2H),2'-pyrrolidine- 3',3''(2''H)-indole]-2,2''-dione
C26H20BrN3O3
Acta Crystallographica Section E (2005) 61, 12 o4254-o4256
a=9.9029(11)Å b=10.2823(11)Å c=11.6261(13)Å
α=104.370(2)° β=94.036(2)° γ=101.771(2)°
4'-(4-Chlorobenzoyl)-1'-methyl-dispiro[indole-3(2H),2'-pyrrolidine- 3',3''(2''H)-indole]-2,2''-dione
C26H20ClN3O3
Acta Crystallographica Section E (2005) 61, 12 o4257-o4259
a=9.795(6)Å b=10.316(6)Å c=11.670(7)Å
α=104.275(9)° β=93.998(10)° γ=102.305(9)°
4'-(4-Methoxybenzoyl)-1'-methyl-dispiro[indole-3(2H),2'-pyrrolidine- 3',3''(2''H)-indole]-2,2''-dione
C27H23N3O4
Acta Crystallographica Section E (2005) 61, 12 o4260-o4262
a=8.684(5)Å b=11.485(7)Å c=22.751(13)Å
α=90.00° β=90.852(10)° γ=90.00°
3-Bromomethyl-1-phenylsulfonyl-1H-indole-2-carbonitrile
C16H11BrN2O2S
Acta Crystallographica Section E (2006) 62, 2 o440-o442
a=8.2689(14)Å b=8.9841(15)Å c=11.805(2)Å
α=77.722(3)° β=86.703(3)° γ=64.795(3)°
4-Benzylidene-1'-methyl-4'-phenylcyclohexanespiro-3'-pyrrolidine-2'-spiro- 3''-indoline-2,2''-dione
C30H28N2O2
Acta Crystallographica Section E (2001) 57, 9 o901-o903
a=12.36240(10)Å b=13.0640(2)Å c=17.1439(3)Å
α=110.0660(10)° β=93.2000(10)° γ=110.5340(10)°
3-(Anthracen-9-yl)-3H-isobenzofuran-1-one
C22H14O2
Acta Crystallographica Section E (2006) 62, 1 o55-o57
a=9.961(4)Å b=10.677(5)Å c=14.073(5)Å
α=90.00° β=90.00° γ=90.00°
1,3-Bis(4-methoxyphenyl)-2-benzothiophene
C22H18O2S
Acta Crystallographica Section E (2006) 62, 1 o49-o51
a=7.508(6)Å b=16.493(9)Å c=27.952(9)Å
α=90.00° β=90.00° γ=90.00°
1-Benzenesulfonyl-2,3-dimethyl-1H-indole
C16H15NO2S
Acta Crystallographica Section E (2006) 62, 1 o85-o87
a=7.8800(13)Å b=9.6020(16)Å c=9.9864(17)Å
α=82.210(3)° β=81.487(3)° γ=71.087(3)°
3-(1,2-Diphenylvinyl)-2-methyl-1-phenylsulfonyl-1H-indole
C29H23NO2S
Acta Crystallographica Section E (2006) 62, 1 o271-o273
a=9.029(3)Å b=14.891(7)Å c=9.8459(17)Å
α=90.00° β=117.588(18)° γ=90.00°
4'-(4-Methylbenzoyl)-1'-methyldispiro[indole-3(2H),2'-pyrrolidine- 3',3''(2''H)-indole]-2,2''-dione
C27H23N3O3
Acta Crystallographica Section E (2006) 62, 1 o52-o54
a=9.6158(10)Å b=10.3812(11)Å c=11.7099(12)Å
α=105.047(2)° β=94.850(2)° γ=100.087(2)°
Spiro[3,4-di(4-chlorophenyl)-4,5-dihydroisoxazole-5,3'-flavan-4'-one]
C29H19Cl2NO3
Acta Crystallographica Section E (2003) 59, 2 o237-o239
a=11.2032(10)Å b=12.349(2)Å c=18.973(5)Å
α=108.890(10)° β=105.090(10)° γ=91.660(10)°
Spiro[3-(4-chlorophenyl)-4-(4-methylphenyl)-4,5-dihydroisoxazole-5,3'- flavan-4'-one]
C30H22ClNO3
Acta Crystallographica Section E (2003) 59, 2 o240-o241
a=14.139(2)Å b=10.939(2)Å c=16.139(3)Å
α=90.00° β=99.809(13)° γ=90.00°
4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
C16H14N2O3S
Acta Crystallographica Section E (2005) 61, 1 o108-o110
a=12.872(2)Å b=9.282(3)Å c=24.761(7)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 5-amino-3-methylisoxazole-4-carboxylate
C7H10N2O3
Acta Crystallographica Section E (2005) 61, 1 o198-o200
a=12.642(2)Å b=8.5036(14)Å c=16.934(3)Å
α=90.00° β=98.488(3)° γ=90.00°
4'-{[2-(But-2-enyl)-4-chloro-5-formyl-1H-imidazol-1-yl]methyl}biphenyl- 2-carbonitrile
C22H18ClN3O
Acta Crystallographica Section E (2005) 61, 1 o25-o26
a=9.080(6)Å b=22.782(15)Å c=10.055(7)Å
α=90.00° β=109.476(10)° γ=90.00°
2-(1-Benzoyl-1-phenylethyl)-3-phenylsulfanyl-1-phenylsulfonyl-1H-indole
C35H27NO3S2
Acta Crystallographica Section E (2005) 61, 3 o578-o580
a=10.0183(8)Å b=12.1239(10)Å c=13.4174(11)Å
α=91.415(2)° β=101.451(2)° γ=112.4730(10)°
Myricetin
C19H18O8
Acta Crystallographica Section E (2005) 61, 4 o846-o848
a=30.958(7)Å b=7.9544(19)Å c=14.263(6)Å
α=90.00° β=95.53(3)° γ=90.00°
(2-Methoxy-5-methylphenyl) phenyl ketone
C15H14O2
Acta Crystallographica Section E (2005) 61, 4 o801-o803
a=10.5883(18)Å b=11.5887(18)Å c=10.0140(17)Å
α=90.00° β=92.904(3)° γ=90.00°
1,2-Bis(2-chlorophenyl)-1,2-bis(3,4-dimethylphenyl)ethane-1,2-diol
C30H28Cl2O2
Acta Crystallographica Section E (2005) 61, 4 o886-o888
a=7.667(2)Å b=22.862(6)Å c=14.654(4)Å
α=90.00° β=104.478(4)° γ=90.00°
4-Phenyl 5-(2-chlorophenyl) 1,2,4-triazole-3-thione
C14H10ClN3S
Acta Crystallographica Section C (1999) 55, 4 581-582
a=6.9693(2)Å b=9.5268(3)Å c=11.1032(4)Å
α=97.5950(10)° β=104.2951(5)° γ=95.327(2)°
1,4-Bis(2-hydroxy-5-methylbenzyl)piperazine
C20H26N2O2
Acta Crystallographica Section C (1999) 55, 12 2147-2149
a=5.8940(10)Å b=8.8060(10)Å c=17.1760(10)Å
α=90.00° β=92.920(10)° γ=90.00°
C19H13ClO
C19H13ClO
Acta Crystallographica Section C (1996) 52, 10 2543-2545
a=10.710(1)Å b=16.485(2)Å c=9.124(1)Å
α=90° β=113.59(1)° γ=90°
N-ethoxycarbonyl-3,5-dimethyl-cis-2,6-diphenyl piperidin-4-one
C22H25NO3
Acta Crystallographica Section C (1998) 54, 6 870-872
a=10.404(2)Å b=9.743(2)Å c=19.096(3)Å
α=90.00° β=95.70(2)° γ=90.00°
1-[2-(napthylenyl)]-3-(4-chlorophenyl)-2-propen-1-one
C19H13ClO
Acta Crystallographica Section C (1997) 53, 7 917-918
a=5.911(4)Å b=7.474(3)Å c=16.366(3)Å
α=100.55(3)° β=91.90(3)° γ=91.62(4)°
1-[2-(napthalenyl)]-3-(3-nitrophenyl)-2-propen-1-one
C19H13NO3
Acta Crystallographica Section C (1998) 54, 4 541-542
a=10.317(2)Å b=5.864(4)Å c=24.5820(10)Å
α=90.00° β=100.15(2)° γ=90.00°
C17H18N2OS
C17H18N2OS
Acta Crystallographica Section C (1993) 49, 1 107-109
a=36.276(7)Å b=10.469(3)Å c=8.229(3)Å
α=90° β=90° γ=90°
C19H13NO3
C19H13NO3
Acta Crystallographica Section C (1996) 52, 12 3145-3146
a=6.060(2)Å b=7.185(3)Å c=16.872(6)Å
α=101.44(3)° β=91.93(3)° γ=86.93(4)°
1-Acetyl-2,6-bis(4-methoxyphenyl)-3-methyl-4-piperidone
C22H25NO4
Acta Crystallographica Section E (2007) 63, 8 o3648
a=17.2799(5)Å b=10.6783(3)Å c=10.5702(3)Å
α=90.00° β=90.9510(10)° γ=90.00°
2-(4-Methoxybenzyl)-3-methyl-1-phenylsulfonyl-1H-indole
C23H21NO3S
Acta Crystallographica Section E (2007) 63, 10 o4134-o4134
a=8.2518(3)Å b=10.0817(4)Å c=12.8169(5)Å
α=97.244(2)° β=97.876(2)° γ=105.709(2)°
Ethyl 2-acetamidomethyl-5-methoxy-1-(phenylsulfonyl)indole-3-carboxylate
C21H22N2O6S
Acta Crystallographica Section E (2007) 63, 11 o4223-o4223
a=12.6551(5)Å b=10.2166(3)Å c=16.0960(6)Å
α=90.00° β=102.738(2)° γ=90.00°
N-Butylpyridine-4-thiocarboxamide
C10H14N2S
Acta Crystallographica Section E (2008) 64, 1 o114-o114
a=8.0895(3)Å b=13.5947(4)Å c=10.4936(3)Å
α=90.00° β=111.895(2)° γ=90.00°
5,7-Bis(1-benzothiophen-2-yl)-2,3-dihydrothieno[3,4-<i>b</i>][1,4]dioxine
C22H14O2S3
Acta Crystallographica Section E (2008) 64, 6 o1049
a=16.1602(5)Å b=8.3524(3)Å c=14.1814(4)Å
α=90.00° β=107.428(2)° γ=90.00°
3-Ethyl-2,6-bis(4-methoxyphenyl)piperidin-4-one
C21H25NO3
Acta Crystallographica Section E (2007) 63, 10 o3985-o3985
a=14.012(2)Å b=7.8060(14)Å c=17.655(3)Å
α=90.00° β=110.401(5)° γ=90.00°
3-(4-Methylphenyl)-1-[(E)-1-(4-methylphenyl)-3-oxo-1-propenyl]-1H-pyrazole -4-carbaldehyde
C21H18N2O2
Acta Crystallographica Section E (2008) 64, 10 o1889
a=10.2914(4)Å b=15.3618(5)Å c=11.0271(4)Å
α=90.00° β=98.7780(10)° γ=90.00°
3-(Cyclohexylsulfanyl)-2-(4-methylphenyl)-5,7-dinitro-1H-indole
C21H21N3O4S
Acta Crystallographica Section E (2008) 64, 10 o1890
a=6.1009(3)Å b=8.5237(4)Å c=19.1522(10)Å
α=83.551(3)° β=84.184(3)° γ=81.157(2)°
4-(2,4-Dichlorophenyl)-2-(1H-indol-3-yl)-6-methoxypyridine-3,5- dicarbonitrile
C22H12Cl2N4O
Acta Crystallographica Section E (2008) 64, 10 o1892
a=9.5394(2)Å b=10.0358(2)Å c=11.1739(3)Å
α=111.9940(10)° β=97.3030(10)° γ=93.7150(10)°
1-Chloroacetyl-3,3-dimethyl-2,6-diphenylpiperidin-4-one
C21H22ClNO2
Acta Crystallographica Section E (2008) 64, 10 o2041
a=13.7005(3)Å b=9.8735(2)Å c=14.8960(3)Å
α=90.00° β=112.7620(10)° γ=90.00°
Methyl 2-benzyl-5-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]-4-nitro-3-phenylpyrrolidine-2-carboxylate
C35H33N3O6
Acta Crystallographica Section E (2008) 64, 10 o1993
a=10.1727(2)Å b=10.4210(2)Å c=15.1680(3)Å
α=91.8330(10)° β=106.1540(10)° γ=102.5360(10)°
Ethyl-1-(4-chlorophenyl)-2-nitro-3-[4-oxo-3-phenyl-1-(4-methoxyphenyl) azetidine-2-yl]-2,3,10,10a-tetrahydro-1H, 5H-pyrrolo[1,2-b] isoquinoline-10a- carboxylate
C37H34ClN3O6
Acta Crystallographica Section E (2008) 64, 10 o2042
a=9.1723(2)Å b=18.0452(4)Å c=19.7475(5)Å
α=90.00° β=100.6380(10)° γ=90.00°
2-Formyl-1-phenylsulfonyl-1H-indole-3-carbonitrile
C16H10N2O3S
Acta Crystallographica Section E (2007) 63, 4 o1906-o1907
a=9.554(2)Å b=12.193(3)Å c=13.637(3)Å
α=103.199(4)° β=95.814(4)° γ=111.969(4)°
N-[(3-Methyl-1-phenylsulfonyl-1H-indol-2-yl)methyl]-1,1-dioxo- 1-benzo[d]isothiazol-3(2H)-one
C23H18N2O5S2
Acta Crystallographica Section E (2007) 63, 4 o2026-o2028
a=8.032(4)Å b=11.146(5)Å c=12.435(6)Å
α=87.321(8)° β=76.633(8)° γ=78.504(8)°
1-(2,4-Dinitrophenyl)-5-ferrocenyl-3-methyl-1H-pyrazole
C20H16FeN4O4
Acta Crystallographica Section E (2008) 64, 2 m265-m265
a=7.1073(2)Å b=11.5339(3)Å c=11.7575(3)Å
α=103.8220(10)° β=93.0610(10)° γ=98.822(2)°
(E)-3-(4-Methylphenyl)-3-[3-(4-methylphenyl)-1H-pyrazol-1-yl]-2-propenal
C20H18N2O
Acta Crystallographica Section E (2008) 64, 11 o2243
a=10.0560(9)Å b=10.0786(8)Å c=10.3176(9)Å
α=62.040(4)° β=79.356(4)° γ=63.038(4)°
Ethyl 4'-ethenyl-2'-oxo-4-phenyl-2-(3,4,5-trimethoxyphenyl)spiro[pyrrolidine-3,3'-indoline]-5-carboxylate monohydrate
C31H32N2O6,H2O
Acta Crystallographica Section E (2008) 64, 11 o2052-o2053
a=38.8029(10)Å b=38.8029(10)Å c=11.0307(3)Å
α=90.00° β=90.00° γ=120.00°
1-(4-Methoxyphenyl)-3,3-bis(methylsulfanyl)-2-phenylprop-2-en-1-one
C18H18O2S2
Acta Crystallographica Section E (2007) 63, 5 o2373-o2374
a=16.471(3)Å b=9.879(4)Å c=22.065(8)Å
α=90.00° β=109.362(17)° γ=90.00°
4-(2,4-Dichlorophenyl)-1,4-dihydro-2-(1H-indol-3-yl)-6-(pyridine-3- carbonitrile
C25H16Cl2N4
Acta Crystallographica Section E (2008) 64, 10 o1891
a=8.0158(9)Å b=10.0261(12)Å c=14.3653(17)Å
α=72.260(6)° β=79.420(6)° γ=78.224(6)°
1-(2,4-Dinitrophenyl)-3-(4-methylphenyl)-4-phenylsulfanyl-1<i>H</i>-pyrazole
C22H16N4O4S
Acta Crystallographica Section E (2008) 64, 11 o2093
a=7.3802(3)Å b=26.6996(11)Å c=10.6691(4)Å
α=90.00° β=106.733(2)° γ=90.00°
4-(4-Chlorophenylsulfanyl)-1-[(<i>E</i>)-2-(4-chlorophenylsulfanyl)-1-phenylethenyl]-3-phenyl-1<i>H</i>-pyrazole
C29H20Cl2N2S2
Acta Crystallographica Section E (2008) 64, 11 o2054-o2055
a=12.3808(4)Å b=21.4667(7)Å c=10.4281(4)Å
α=90.00° β=108.181(2)° γ=90.00°
6,7-Dihydrodibenz[e,g]azulen-8(5H)-one
C18H14O
Acta Crystallographica Section C (2000) 56, 7 824-826
a=8.0547(11)Å b=17.378(2)Å c=17.919(3)Å
α=90.00° β=90.00° γ=90.00°
12,13-Dihydrobenzo[e]napth[2,1-g]azulen-14(11H)-one
C22H16O
Acta Crystallographica Section C (2000) 56, 7 824-826
a=11.8466(12)Å b=12.4890(15)Å c=20.703(2)Å
α=90.00° β=90.00° γ=90.00°
4,4-Dimethoxy-7,11-diphenyl-2,4-diazaspiro[5.5]undecane-1,3,5-trione monohydrate
C23H24N2O5,H2O1
Acta Crystallographica Section C (2002) 58, 11 o678-o680
a=14.559(2)Å b=10.755(2)Å c=15.346(4)Å
α=90° β=114.100(10)° γ=90°
1-N-Methyl-t-3-isopropyl-r-2,c-6-diphenylpiperidone Thiosemicarbazone
C22H28N4S
Acta Crystallographica Section C (2003) 59, 6 o346-o348
a=11.1794(17)Å b=10.0720(16)Å c=19.591(3)Å
α=90.00° β=94.317(3)° γ=90.00°
4-[3-(3,4-Dimethoxyphenyl)prop-2-enoyl]phenyl methacrylate
C21H20O5
Acta Crystallographica Section C (2002) 58, 1 o26-o28
a=13.381(2)Å b=20.813(2)Å c=13.881(2)Å
α=90.00° β=109.680(10)° γ=90.00°
4-[3-(2-bromophenyl)prop-2-enoyl]phenyl methacrylate
C19H15BrO3
Acta Crystallographica Section C (2002) 58, 1 o26-o28
a=7.5272(3)Å b=10.1940(4)Å c=11.5780(4)Å
α=96.2270(10)° β=98.4280(10)° γ=108.7630(10)°
R-2,c-6-Bis(4-methoxyphenyl)-c-3,t-3-dimethyl-1-nitrosopiperidin-4-one
C21H24N2O4
Acta Crystallographica Section E (2009) 65, 6 o1420
a=7.2540(3)Å b=15.0469(6)Å c=17.0741(7)Å
α=90.00° β=90.00° γ=90.00°
Diethyl 2-[(5-methoxy-2-methyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)methylene]malonate
C24H25NO7S
Acta Crystallographica Section E (2009) 65, 6 o1418-o1419
a=8.7597(2)Å b=10.9029(2)Å c=12.5186(3)Å
α=88.4020(10)° β=79.7230(10)° γ=83.635(2)°
3'-Benzyloxy-3-hydroxy-3,3'-bi-1<i>H</i>-indole-2,2'(3<i>H</i>,3'<i>H</i>)-dione monohydrate
C23H18N2O4,H2O
Acta Crystallographica Section E (2009) 65, 5 o994
a=9.8243(3)Å b=9.9304(6)Å c=11.4460(5)Å
α=107.517(2)° β=114.227(3)° γ=93.918(2)°
4-(4-Chlorophenyl)-6-methoxy-2,2'-bipyridine-5-carbonitrile
C18H12ClN3O
Acta Crystallographica Section E (2009) 65, 5 o995
a=9.5869(5)Å b=13.8761(7)Å c=12.2124(6)Å
α=90.00° β=106.896(2)° γ=90.00°
4-(2, 4-Dichlorophenyl)-6-(1H-indol-3-yl)-2,2'-bipyridine-5-carbonitrile
C25H14Cl2N4
Acta Crystallographica Section E (2009) 65, 5 o996-o997
a=10.0307(12)Å b=22.446(3)Å c=17.932(3)Å
α=90.00° β=90.991(4)° γ=90.00°
5-Chloroacetyl-4-methyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C12H13ClN2O2
Acta Crystallographica Section E (2009) 65, 10 o2361
a=16.7656(4)Å b=8.8171(2)Å c=17.0125(4)Å
α=90.00° β=105.8030(10)° γ=90.00°
4-Methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine-5-carbaldehyde
C11H12N2O2
Acta Crystallographica Section E (2009) 65, 10 o2362
a=5.32840(10)Å b=12.9387(4)Å c=14.6227(5)Å
α=90.00° β=97.968(2)° γ=90.00°
2,2,4-Trimethyl-5-(4-tolylsulfonyl)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine
C19H24N2O2S
Acta Crystallographica Section E (2009) 65, 10 o2363-o2364
a=7.3658(3)Å b=14.8013(8)Å c=17.4556(10)Å
α=90.00° β=90.00° γ=90.00°
N~5~-Dichloroacetyltetrahydro-4-methyl-1,5-benzodiazepin-2-one hemihydrate
2(C12H12Cl2N2O2),H2O
Acta Crystallographica Section E (2009) 65, 10 o2551-o2552
a=8.5470(3)Å b=18.0837(6)Å c=8.8697(3)Å
α=90.00° β=95.405(2)° γ=90.00°
(Benzylamine)chloridobis(ethane-1,2-diamine)cobalt(III) dichloride hemihydrate
C11H25ClCoN52,2(Cl),0.5(H2O)
Acta Crystallographica Section E (2009) 65, 10 m1174-m1175
a=20.9361(9)Å b=7.2447(3)Å c=24.4340(9)Å
α=90.00° β=106.440(2)° γ=90.00°
4-(4-Bromophenyl)-6-(1<i>H</i>-indol-3-yl)-2,2'-bipyridine-5-carbonitrile
C25H15BrN4
Acta Crystallographica Section E (2009) 65, 3 o450
a=14.7393(4)Å b=10.7465(3)Å c=25.4251(7)Å
α=90.00° β=90.00° γ=90.00°
2-(1<i>H</i>-indol-3-ylcarbonyl)acetonitrile
C11H8N2O
Acta Crystallographica Section E (2009) 65, 3 o447
a=7.3439(2)Å b=7.3534(2)Å c=18.2475(5)Å
α=83.402(2)° β=78.890(2)° γ=73.5010(10)°
3-(4-Methoxybenzyl)-2-methyl-1-phenylsulfonyl-1<i>H</i>-indole
C23H21NO3S
Acta Crystallographica Section E (2009) 65, 4 o847
a=11.4366(4)Å b=13.6021(5)Å c=14.0001(5)Å
α=74.1540(10)° β=67.773(2)° γ=88.848(2)°
1-Formyl-r-2,c-6-bis(4-methoxyphenyl)-c-3,t-3-dimethylpiperidin-4-one
C22H25NO4
Acta Crystallographica Section E (2009) 65, 4 o856
a=11.7274(3)Å b=18.8556(4)Å c=9.7178(3)Å
α=90.00° β=113.5070(10)° γ=90.00°
Diethyl 1,1-dioxo-3,5-bis(pyridin-2-yl)-1λ^6^,4-thiomorpholine-2,6-dicarboxylate
C20H23N3O6S
Acta Crystallographica Section E (2011) 67, 2 o305
a=20.7258(13)Å b=8.3921(5)Å c=24.4923(15)Å
α=90.00° β=90.00° γ=90.00°
Diethyl 2-[(2-benzyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)methylene]malonate
C29H27NO6S
Acta Crystallographica Section E (2009) 65, 1 o12
a=10.8280(9)Å b=13.7762(11)Å c=17.6832(16)Å
α=90.00° β=91.341(4)° γ=90.00°
1-Dichloroacetyl-3,3-dimethyl-2,6-diphenylpiperidin-4-one
C21H21Cl2NO2
Acta Crystallographica Section E (2009) 65, 1 o10
a=9.1084(2)Å b=10.8992(3)Å c=10.9918(3)Å
α=63.8790(10)° β=85.343(2)° γ=79.0290(10)°
1-Dichloroacetyl-r-2,c-6-bis(4-methoxyphenyl)-c-3,t-3-dimethylpiperidin-4-one
C23H25Cl2NO4
Acta Crystallographica Section E (2009) 65, 1 o11
a=23.6295(9)Å b=10.3999(4)Å c=19.2617(9)Å
α=90.00° β=107.7340(10)° γ=90.00°
Ethyl 2-[<i>N</i>-(2-formylphenyl)benzenesulfonamido]acetate
C17H17NO5S
Acta Crystallographica Section E (2009) 65, 3 o483
a=11.3512(6)Å b=11.7820(6)Å c=12.8045(6)Å
α=90.00° β=90.00° γ=90.00°
T-3-Ethyl-r-2,c-6-bis(4-methoxyphenyl)-1-nitrosopiperidin-4-one
C21H24N2O4
Acta Crystallographica Section E (2009) 65, 8 o1765
a=7.2742(4)Å b=15.8459(7)Å c=16.4800(7)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-(3-ethoxy-4-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate monohydrate
C15H18N2O5,H2O
Acta Crystallographica Section E (2009) 65, 8 o1921-o1922
a=11.4927(6)Å b=15.3756(8)Å c=8.9240(5)Å
α=90.00° β=95.932(2)° γ=90.00°
1-chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethyl-piperidin-4-one oxime
C21H21Cl3N2O2
Acta Crystallographica Section E (2010) 66, 6 o1506
a=9.8147(6)Å b=15.5929(11)Å c=13.9498(9)Å
α=90.00° β=93.529(4)° γ=90.00°
1-Formyl-<i>t</i>-3,<i>t</i>-5-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C20H21NO2
Acta Crystallographica Section E (2010) 66, 6 o1505
a=7.4303(4)Å b=15.3567(6)Å c=29.6732(13)Å
α=90.00° β=90.00° γ=90.00°
1-(Dicyanomethylene)-2,3,4-tetrahydrocarbazole
C15H11N3
Acta Crystallographica Section E (2010) 66, 11 o2965
a=7.7631(10)Å b=8.0003(10)Å c=9.8933(13)Å
α=87.461(8)° β=82.392(8)° γ=75.038(7)°